185 related articles for article (PubMed ID: 11965102)
21. Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers.
Lee NY; O'Meara W; Chan K; Della-Bianca C; Mechalakos JG; Zhung J; Wolden SL; Narayana A; Kraus D; Shah JP; Pfister DG
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):459-68. PubMed ID: 17493769
[TBL] [Abstract][Full Text] [Related]
22. [Epidermoid carcinoma of piriform sinus after chemo-radiotherapy: acoustic evaluation and voice handicap].
Dubois MD; Crevier-Buchman L; Martin C; Prades JM
Rev Laryngol Otol Rhinol (Bord); 2006; 127(5):299-304. PubMed ID: 17425004
[TBL] [Abstract][Full Text] [Related]
23. [Rationale and progress of the phase III trial: intensification of the treatment of locally advanced squamous cell carcinoma of the anal canal].
Peiffert D
Cancer Radiother; 2003 Nov; 7 Suppl 1():100s-107s. PubMed ID: 15124551
[TBL] [Abstract][Full Text] [Related]
24. Concurrent chemoradiotherapy with cisplatin, 5-fluorouracil, methotrexate, and leucovorin in patients with advanced resectable squamous cell carcinoma of the larynx and hypopharynx.
Taguchi T; Tsukuda M; Mikami Y; Matsuda H; Horiuchi C; Yoshida T; Nishimura G; Ishitoya J; Katori H
Acta Otolaryngol; 2006 Apr; 126(4):408-13. PubMed ID: 16608794
[TBL] [Abstract][Full Text] [Related]
25. Tumor angiogenesis as a predictive marker for organ preservation in patients with advanced laryngeal carcinoma.
Teknos TN; Cox C; Barrios MA; Chepeha DB; Bradford CR; Fisher SG; Wolf GT
Laryngoscope; 2002 May; 112(5):844-51. PubMed ID: 12150616
[TBL] [Abstract][Full Text] [Related]
26. Candidates for larynx preservation: the next step?
Lefebvre JL
Oncologist; 2010; 15 Suppl 3():30-2. PubMed ID: 21036887
[TBL] [Abstract][Full Text] [Related]
27. Searching for less toxic larynx preservation: a need for common definitions and metrics.
Forastiere AA; Trotti AM
J Natl Cancer Inst; 2009 Feb; 101(3):129-31. PubMed ID: 19176460
[No Abstract] [Full Text] [Related]
28. [Preoperative chemoradiation in esophageal cancer: experience of a single center in 102 patients].
Imdahl A; Schöffel U; Ruf G; Hopf UT
Zentralbl Chir; 2004 Oct; 129(5):350-5. PubMed ID: 15486784
[TBL] [Abstract][Full Text] [Related]
29. Concurrent chemoradiotherapy for T4 patients with hypopharyngeal and laryngeal squamous cell carcinomas.
Nishimura G; Tsukuda M; Horiuchi C; Satake K; Yoshida T; Nagao J; Kawakami M; Kondo N; Arai Y; Taguchi T; Matsuda H; Mikami Y
Auris Nasus Larynx; 2007 Dec; 34(4):499-504. PubMed ID: 17604583
[TBL] [Abstract][Full Text] [Related]
30. [Pancreatic cancer. The relative importance of neoadjuvant therapy].
Beger HG; Poch B; Schwarz M; Gansauge F
Chirurg; 2003 Mar; 74(3):202-7. PubMed ID: 12647076
[TBL] [Abstract][Full Text] [Related]
31. [Role of chemotherapy in squamous cell tumors of the larynx].
Merlano M; Benasso M; Cavallari M; Muttini MP
Acta Otorhinolaryngol Ital; 1991; 11 Suppl 33():129-34. PubMed ID: 1718139
[No Abstract] [Full Text] [Related]
32. [Results of an organ conservation protocol in patients with locally advanced laryngeal tumours].
León X; López M; García J; Quer M
Acta Otorrinolaringol Esp; 2009; 60(3):176-85. PubMed ID: 19558903
[TBL] [Abstract][Full Text] [Related]
33. [Clinical characteristics and multivariate analysis of prognostic factors in recurrent laryngeal carcinoma].
Chen YF; Chen FJ; Yang AK; Zeng ZY; Song M; Li QL
Ai Zheng; 2004 May; 23(5):584-8. PubMed ID: 15142460
[TBL] [Abstract][Full Text] [Related]
34. Laryngeal preservation by treatment with induction chemotherapy and radiotherapy protocol for stage III & IV carcinoma larynx--results of a pilot study.
Thakar A; Bahadur S; Tandon DA; Ranganathan A; Rath GK
J Laryngol Otol; 1999 May; 113(5):433-8. PubMed ID: 10505156
[TBL] [Abstract][Full Text] [Related]
35. [The reconstruction of laryngeal function in subtotal laryngectomy with preservation of arytenoid cartilage].
Zhou L; Song Y; Geng D
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Oct; 34(5):309-10. PubMed ID: 12764833
[TBL] [Abstract][Full Text] [Related]
36. [Radiation and concomitant chemotherapy after surgery for breast cancer].
Calais G
Cancer Radiother; 2004 Feb; 8(1):39-47. PubMed ID: 15093200
[TBL] [Abstract][Full Text] [Related]
37. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
38. Expression of Bcl-2 family proteins in advanced laryngeal squamous cell carcinoma: correlation with response to chemotherapy and organ preservation.
Trask DK; Wolf GT; Bradford CR; Fisher SG; Devaney K; Johnson M; Singleton T; Wicha M
Laryngoscope; 2002 Apr; 112(4):638-44. PubMed ID: 12150516
[TBL] [Abstract][Full Text] [Related]
39. Clinical predictors of larynx preservation after multiagent concurrent chemoradiotherapy.
Rodriguez CP; Adelstein DJ; Rybicki LA; Saxton JP; Lorenz RR; Wood BG; Strome M; Esclamado RM; Lavertu P; Carroll MA
Head Neck; 2008 Dec; 30(12):1535-42. PubMed ID: 18704968
[TBL] [Abstract][Full Text] [Related]
40. Accelerated radiotherapy for advanced laryngeal cancer.
Haugen H; Johansson KA; Ejnell H; Edström S; Mercke C
Acta Oncol; 2005; 44(5):481-9. PubMed ID: 16118082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
